lifestyle.marketresearchjournals.com

Author: Chamberlain Communications Group LLC, a Syneos HealthTM group company

Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi

April 1, 2026
/C O R R E C T I O N — American Academy of Pediatrics/

March 16, 2026
Federal Judge Blocks Immunization Schedule Changes, Stays ACIP Member Appointments

March 16, 2026
Tanabe Pharma America to Highlight Research in ALS at 2026 MDA Clinical and Scientific Conference

March 5, 2026
Tanabe Pharma America Announces Positive Topline Results for Dersimelagon in Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)

January 24, 2026
Leading Public Health Groups Seek Expedited Injunctive Relief Against Immunization Schedule Changes, Upcoming ACIP Meeting; Hearing Scheduled Friday, February 13

January 12, 2026
Court Rejects HHS’s Motion to Dismiss Lawsuit Brought by Leading Public Health Groups Against HHS Immunization Schedule Changes, ACIP Reconstitution

January 6, 2026
Leading Medical and Public Health Groups Request Transparency, Evidence Behind Changing ACIP Recommendations in Court Hearing

December 30, 2025
Tanabe Pharma America Announces Transfer of RADICAVA® Business to Shionogi

December 22, 2025
Connections to Expand Access to Care in Seattle, Washington

November 23, 2025